Evan Vosburgh

Evan Vosburgh, MD is an Associate Clinical Professor of Medicine at Yale University's Yale School of Medicine, specializing in hematology and oncology. He is affiliated with the West Haven Veterans Hospital and the Yale Primary Care Center. His research focuses on neuroendocrine cancers, amyloidosis, and clotting disorders. He holds board certifications in Medical Oncology and Internal Medicine.

Education:

• Fellowship: Boston University School of Medicine (1989)
• MD: Albany Medical College (1982)
• BS: Duke University (1977)

Research Interests: Dr. Vosburgh’s work centers on neuroendocrine tumor biology, including genetic mechanisms and mouse models. His studies explore tumor suppressor genes (e.g., Rb1, Trp53), pancreatic neuroendocrine tumor progression, and novel therapeutic approaches. He has contributed to advancements in high-throughput tumor spheroid imaging and 3D cell line models for drug testing.

Publications: His recent work includes studies on neuroendocrine tumor classification, genetic drivers of tumor formation, and metastasis mechanisms. Collaborations with institutions like the Yale Cancer Center highlight interdisciplinary approaches to oncology.

Professional Affiliations:

• American Association of Cancer Research (Member since 2004)
• American Society of Clinical Oncology (Member since 2004)
• American Society of Hematology (Member since 2004)

Labs/Teams: Active in the Cancer Signaling Networks and Yale Cancer Center research groups.